Bolte Axel (CIK 1579247) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-03). Recent activity: Sell INZY (423,926 shares), Buy INZY (152,823 shares), Buy INZY (4,407 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-03 | Inozyme Pharma, Inc. (INZY) | Director | Sell | 423,926 | $1.7M |
| 2025-05-20 | Inozyme Pharma, Inc. (INZY) | Director | Buy | 152,823 | $149,767 |
| 2025-05-20 | Inozyme Pharma, Inc. (INZY) | Director | Buy | 4,407 | $4,319 |
Source: SEC Form 4 filings · as of 2025-07-03